- Home
- News
- Treatment & Care
- HIV Worldwide
- Living with HIV
- Preventing HIV
- Organisations
- HIV Basics
- About Us
information for people living and working with HIV
Patient Information Booklets
- HIV and anti-HIV drugs
- Types of antiretroviral drugs
- Where antiretrovirals block HIV
- Nucleoside/nucleotide analogue reverse transcriptase inhibitors (NRTIs)
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
- Protease inhibitors (PIs)
- Fusion and entry inhibitors
- Integrase inhibitors
- Summary
feedback
Give us your views on our work
Integrase inhibitors
raltegravir
Names: raltegravir, Isentress
Dose: One oval pink 400mg tablet twice daily.
Tips on taking it: take with or without food.
Common Side‑effects: diarrhoea, nausea and headache.
Resistance to raltegravir: there is currently little information.
Key drug interactions: can affect blood levels of tipranavir/ritonavir and atazanavir/ritonavir, but it is not necessary to adjust drug doses because of this. The anti‑TB drug rifampicin can lower blood levels of raltegravir.